Cannabidiol (CBD) in Cancer Management

Kylie O’Brien

Research output: Contribution to journalArticlepeer-review

Abstract

The plant Cannabis sativa has been in use medicinally for several thousand years. It has over 540 metabolites thought to be responsible for its therapeutic effects. Two of the key phytocannabinoids are cannabidiol (CBD) and tetrahydrocannabinol (THC). Unlike THC, CBD does not have potentially intoxicating effects. Preclinical and clinical research indicates that CBD has a wide range of therapeutic effects, and many of them are relevant to the management of cancer. In this article, we explore some of the potential mechanisms of action of CBD in cancer, and evidence of its efficacy in the integrative management of cancer including the side effects associated with its treatment, demonstrating its potential for integration with orthodox cancer care.
Original languageEnglish
JournalCancers
Volume14
Issue number4
DOIs
Publication statusPublished - 2022
Externally publishedYes

Fingerprint

Dive into the research topics of 'Cannabidiol (CBD) in Cancer Management'. Together they form a unique fingerprint.

Cite this